1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY MODALITY
5.1. Introduction
5.2. Portable Devices
5.3. Hand-Held Devices
5.4. Bench-Top Devices
6. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY PRODUCT TYPE
6.1. Introduction
6.2. RFID Analyzer
6.3. Scanning and Imaging Systems
6.4. Chromatographs
6.5. Spectrometers
6.6. Spectroscopes
7. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY TECHNOLOGY
7.1. Introduction
7.2. Infrared and Near-Infrared Spectroscopy
7.3. Microfluidic (Benchtop and Handheld Devices)
7.4. Rapid Chemical Testing
7.5. Raman Spectroscopy
7.6. RFID Technology
7.7. Other
8. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY END-USER
8.1. Introduction
8.2. Pharmaceutical Companies
8.3. Drug Testing Laboratories
8.4. Research Organizations
9. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Italy
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. Taiwan
9.6.5. Thailand
9.6.6. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Bayer AG
11.2. Thermo Fisher Scientific Inc.
11.3. Spectral Engines Oy
11.4. GAO Group
11.5. Systech International
11.6. Advanced Systems Development, Inc.
11.7. B&W Tek
11.8. Centice Corporation
11.9. Consumer Physics
11.10. Global Pharma HealthCare Ltd.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF TABLES
LIST OF FIGURES